Abstract
Abstract
Purpose of Review
This narrative review article aims to show the actual role of imaging, in particular MRI, and the role of VI-RADS Score, in recognition and follow-up of the tumor.
Recent Findings
A team of professionals created VI-RADS with the goal of standardizing the acquisition and interpretation of multiparametric-MRI in bladder cancer.
Summary
Bladder cancer is the most common cancer involving the urinary system. It is the fourth most common urological cancer in men and the second most frequent cancer affecting the urinary tract. Main risks factors are advanced age, male sex, and cigarette smoking. Bladder cancer ranges from unaggressive and usually non-invasive tumors that recur and commit patients to long-term invasive surveillance, to aggressive and invasive tumors with high disease-specific mortality. At the time of diagnosis, 70% of patients are experiencing non-muscle-invasive bladder cancer. Vesical imaging-reporting and data system score (VI-RADS) is a scoring system useful to standardize the approach to multiparametric-MRI interpretation, and reporting for bladder cancer.
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging
Reference37 articles.
1. Shinagare AB, Sadow CA, Sahni VA, Silverman SG. Urinary bladder: normal appearance and mimics of malignancy at CT urography. Cancer Imaging. 2011;11(1):100–8. https://doi.org/10.1102/1470-7330.2011.0017. (Published 28 June 2011).
2. Sam P, Nassereddin A, LaGrange CA. Anatomy, abdomen and pelvis, bladder detrusor muscle. In: StatPearls. Treasure Island: StatPearls Publishing; 2021.
3. Bolla SR, Odeluga N, Jetti R. Histology, bladder. In: StatPearls. Treasure Island: StatPearls Publishing; 2022.
4. Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol. 2017;71(1):96–108. https://doi.org/10.1016/j.eururo.2016.06.010.
5. Rozanec JJ, Secin FP. Epidemiología, etiología, prevención del cáncer vesical [Epidemiology, etiology and prevention of bladder cancer]. Arch Esp Urol. 2020;73(10):872–8.